163 related articles for article (PubMed ID: 19681308)
1. Influence of cardiopulmonary bypass on the interaction of recombinant factor VIIa with activated platelets.
Kjalke M; Runge M; Rojkjaer R; Steinbruchel D; Johansson PI
J Extra Corpor Technol; 2009 Jun; 41(2):97-104. PubMed ID: 19681308
[TBL] [Abstract][Full Text] [Related]
2. Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and a glycoprotein VI receptor agonist.
Kjalke M; Kjellev S; Rojkjaer R
J Thromb Haemost; 2007 Apr; 5(4):774-80. PubMed ID: 17229056
[TBL] [Abstract][Full Text] [Related]
3. Development of a flow cytometric assay for detection of coated platelets in dogs and evaluation of binding of coated platelets to recombinant human coagulation factor VIIa.
Knudsen T; Kjalke M; Tranholm M; Nichols TC; Jensen AL; Kristensen AT
Am J Vet Res; 2011 Aug; 72(8):1007-14. PubMed ID: 21801056
[TBL] [Abstract][Full Text] [Related]
4. The in vitro effect of recombinant factor VIIa on coated platelet formation and clot dynamics of stored platelet concentrates.
Svendsen MS; Kristensen AT; Bochsen L; Salado-Jimena JA; Johansson PI
Transfusion; 2009 Oct; 49(10):2186-94. PubMed ID: 19527478
[TBL] [Abstract][Full Text] [Related]
5. The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery.
Sørensen B; Asvaldsdottir HS; Gudmundsdottir BR; Onundarson PT
Thromb Res; 2009 Dec; 124(6):695-700. PubMed ID: 19733387
[TBL] [Abstract][Full Text] [Related]
6. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).
Tanaka KA; Taketomi T; Szlam F; Calatzis A; Levy JH
Anesth Analg; 2008 Mar; 106(3):732-8, table of contents. PubMed ID: 18292410
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of thrombin generation in neonates undergoing cardiopulmonary bypass.
Guzzetta NA; Szlam F; Kiser AS; Fernandez JD; Szlam AD; Leong T; Tanaka KA
Br J Anaesth; 2014 Feb; 112(2):319-27. PubMed ID: 24193321
[TBL] [Abstract][Full Text] [Related]
8. Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass.
Percy CL; Hartmann R; Jones RM; Balachandran S; Mehta D; Dockal M; Scheiflinger F; O'Donnell VB; Hall JE; Collins PW
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):357-67. PubMed ID: 25928274
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count.
Lisman T; Adelmeijer J; Cauwenberghs S; Van Pampus EC; Heemskerk JW; De Groot PG
J Thromb Haemost; 2005 Apr; 3(4):742-51. PubMed ID: 15842358
[TBL] [Abstract][Full Text] [Related]
10. Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generation.
Lisman T; Adelmeijer J; Heijnen HF; de Groot PG
Blood; 2004 Mar; 103(5):1720-7. PubMed ID: 14592825
[TBL] [Abstract][Full Text] [Related]
11. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
Guzzetta NA; Huch S; Fernandez JD; Tosone SR; Miller BE
Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
[TBL] [Abstract][Full Text] [Related]
12. Redistribution and hemostatic action of recombinant activated factor VII associated with platelets.
Lopez-Vilchez I; Hedner U; Altisent C; Diaz-Ricart M; Escolar G; Galan AM
Am J Pathol; 2011 Jun; 178(6):2938-48. PubMed ID: 21641410
[TBL] [Abstract][Full Text] [Related]
13. General haemostatic agents--fact or fiction?
Hedner U
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets.
Gabriel DA; Li X; Monroe DM; Roberts HR
J Thromb Haemost; 2004 Oct; 2(10):1816-22. PubMed ID: 15456494
[TBL] [Abstract][Full Text] [Related]
15. Activation of platelets in whole blood by recombinant factor VIIa by a thrombin-dependent mechanism.
Wilbourn B; Harrison P; Mackie IJ; Liesner R; Machin SJ
Br J Haematol; 2003 Aug; 122(4):651-61. PubMed ID: 12899721
[TBL] [Abstract][Full Text] [Related]
16. Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation.
Lisman T; Moschatsis S; Adelmeijer J; Nieuwenhuis HK; De Groot PG
Blood; 2003 Mar; 101(5):1864-70. PubMed ID: 12411291
[TBL] [Abstract][Full Text] [Related]
17. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
18. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
[TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of the effect of pump type and heparin-coated surfaces on platelets during cardiopulmonary bypass.
Misoph M; Babin-Ebell J; Schwender S
Thorac Cardiovasc Surg; 1997 Dec; 45(6):302-6. PubMed ID: 9477463
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa enhances platelet deposition from flowing haemophilic blood but requires the contact pathway to promote fibrin deposition.
Li R; Panckeri KA; Fogarty PF; Diamond SL
Haemophilia; 2015 Mar; 21(2):266-274. PubMed ID: 25311576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
